Alkermes’ Corporate Presentation to be Webcast at the Jefferies 2015 London Healthcare Conference
November 11 2015 - 4:00PM
Business Wire
Alkermes plc (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live at the Jefferies 2015 London
Healthcare Conference on Wednesday, Nov. 18, 2015, at 10:40 a.m.
GMT (5:40 a.m. EST) from London, England. The presentation may be
accessed under the Investors tab on www.alkermes.com and will be
archived for 14 days.
Alkermes plc is a fully integrated, global
biopharmaceutical company developing innovative medicines for the
treatment of central nervous system (CNS) diseases. The company has
a diversified commercial product portfolio and a substantial
clinical pipeline of product candidates for chronic diseases that
include schizophrenia, depression, addiction and multiple
sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an
R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing
facility in Wilmington, Ohio. For more information, please visit
Alkermes’ website at www.alkermes.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151111006119/en/
Alkermes plcEva Stroynowski, +1 781-609-6823Corporate
Communications
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Alkermes (NASDAQ:ALKS)
Historical Stock Chart
From Sep 2023 to Sep 2024